These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 30813015)
1. An efficient prodrug-based nanoscale delivery platform constructed by water soluble eight-arm-polyethylene glycol-diosgenin conjugate. Li C; Dai J; Zheng D; Zhao J; Tao Y; Lei J; Xi X; Liu J Mater Sci Eng C Mater Biol Appl; 2019 May; 98():153-160. PubMed ID: 30813015 [TBL] [Abstract][Full Text] [Related]
2. A novel self-assembled nanoparticle platform based on pectin-eight-arm polyethylene glycol-drug conjugates for co-delivery of anticancer drugs. Liu Y; Liu K; Li X; Xiao S; Zheng D; Zhu P; Li C; Liu J; He J; Lei J; Wang L Mater Sci Eng C Mater Biol Appl; 2018 May; 86():28-41. PubMed ID: 29525094 [TBL] [Abstract][Full Text] [Related]
3. Self-assembled targeted folate-conjugated eight-arm-polyethylene glycol-betulinic acid nanoparticles for co-delivery of anticancer drugs. Dai L; Cao X; Liu KF; Li CX; Zhang GF; Deng LH; Si CL; He J; Lei JD J Mater Chem B; 2015 May; 3(18):3754-3766. PubMed ID: 32262850 [TBL] [Abstract][Full Text] [Related]
4. Targeted Delivery of Dual Anticancer Drugs Based on Self-Assembled iRGD-Modified Soluble Drug-Polymer Pattern Conjugate Nanoparticles. Li C; Chen Z; Zheng D; Zhao J; Lei J ACS Appl Bio Mater; 2021 Feb; 4(2):1499-1507. PubMed ID: 35014499 [TBL] [Abstract][Full Text] [Related]
5. A novel self-assembled pH-sensitive targeted nanoparticle platform based on antibody-4arm-polyethylene glycol-pterostilbene conjugates for co-delivery of anticancer drugs. Liu KF; Liu YX; Dai L; Li CX; Wang L; Liu J; Lei JD J Mater Chem B; 2018 Jan; 6(4):656-665. PubMed ID: 32254494 [TBL] [Abstract][Full Text] [Related]
6. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
7. Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules. Guo Y; Wang T; Zhao S; Qiu H; Han M; Dong Z; Wang X Eur J Pharm Sci; 2018 Nov; 124():266-272. PubMed ID: 30189259 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization. Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001 [TBL] [Abstract][Full Text] [Related]
9. Development of Novel Lignin-Based Targeted Polymeric Nanoparticle Platform for Efficient Delivery of Anticancer Drugs. Liu K; Zheng D; Lei H; Liu J; Lei J; Wang L; Ma X ACS Biomater Sci Eng; 2018 May; 4(5):1730-1737. PubMed ID: 33445330 [TBL] [Abstract][Full Text] [Related]
10. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739 [TBL] [Abstract][Full Text] [Related]
11. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
12. Reversibly "double locked" hydroxycamptothecin prodrug nanoparticles for targeted chemotherapy of lung cancer. Zhang J; Wang B; Wang H; Wang Z; Zhang P; Huang X; Qian H; Huang D; Chen W; Zhong Y Acta Biomater; 2023 Aug; 166():593-603. PubMed ID: 37220820 [TBL] [Abstract][Full Text] [Related]
13. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate. Liu K; Dai L; Li C; Liu J; Wang L; Lei J Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate. Liao AM; Zhang Y; Hou Y; Huang JH; Hui M; Lee KK; Lee KY; Chun C Food Chem Toxicol; 2021 May; 151():112101. PubMed ID: 33684518 [TBL] [Abstract][Full Text] [Related]
15. Glutathione-responsive self-delivery nanoparticles assembled by curcumin dimer for enhanced intracellular drug delivery. Zhang H; Zhang Y; Chen Y; Zhang Y; Wang Y; Zhang Y; Song L; Jiang B; Su G; Li Y; Hou Z Int J Pharm; 2018 Oct; 549(1-2):230-238. PubMed ID: 30071310 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692 [TBL] [Abstract][Full Text] [Related]
17. A novel self-assembled targeted nanoparticle platform based on carboxymethylcellulose co-delivery of anticancer drugs. Dai L; Liu KF; Si CL; He J; Lei JD; Guo LQ J Mater Chem B; 2015 Aug; 3(32):6605-6617. PubMed ID: 32262797 [TBL] [Abstract][Full Text] [Related]
18. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy. Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434 [TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma. Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363 [No Abstract] [Full Text] [Related]
20. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. Zhao Y; Chen F; Pan Y; Li Z; Xue X; Okeke CI; Wang Y; Li C; Peng L; Wang PC; Ma X; Liang XJ ACS Appl Mater Interfaces; 2015 Sep; 7(34):19295-305. PubMed ID: 26270258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]